These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32183364)

  • 21. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
    Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
    Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J
    Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.
    Maier C; Herkommer K; Luedeke M; Rinckleb A; Schrader M; Vogel W
    Prostate; 2014 Oct; 74(14):1444-51. PubMed ID: 25111659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Clinical and Genetic Analysis of
    Kirchner K; Gamulin M; Kulis T; Sievers B; Kastelan Z; Lessel D
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
    Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB
    Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
    Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.
    Paulo P; Cardoso M; Brandão A; Pinto P; Falconi A; Pinheiro M; Cerveira N; Silva R; Santos C; Pinto C; Peixoto A; Maia S; Teixeira MR
    Genes Chromosomes Cancer; 2023 Dec; 62(12):710-720. PubMed ID: 37436117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene.
    Cardoso M; Maia S; Brandão A; Sahasrabudhe R; Lott P; Belter N; Carvajal-Carmona LG; Paulo P; Teixeira MR
    Br J Cancer; 2023 Apr; 128(6):1077-1085. PubMed ID: 36564567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
    Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
    Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
    Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
    Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
    Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
    Nicolas E; Arora S; Zhou Y; Serebriiskii IG; Andrake MD; Handorf ED; Bodian DL; Vockley JG; Dunbrack RL; Ross EA; Egleston BL; Hall MJ; Golemis EA; Giri VN; Daly MB
    Oncotarget; 2015 Nov; 6(37):39614-33. PubMed ID: 26485759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.
    Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA
    J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline BRCA1 mutations increase prostate cancer risk.
    Leongamornlert D; Mahmud N; Tymrakiewicz M; Saunders E; Dadaev T; Castro E; Goh C; Govindasami K; Guy M; O'Brien L; Sawyer E; Hall A; Wilkinson R; Easton D; ; Goldgar D; Eeles R; Kote-Jarai Z
    Br J Cancer; 2012 May; 106(10):1697-701. PubMed ID: 22516946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.
    Wu Y; Yu H; Li S; Wiley K; Zheng SL; LaDuca H; Gielzak M; Na R; Sarver BAJ; Helfand BT; Walsh PC; Lotan TL; Cooney KA; Black MH; Xu J; Isaacs WB
    Eur Urol Oncol; 2020 Apr; 3(2):224-230. PubMed ID: 31948886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PALB2 variants in hereditary and unselected Finnish prostate cancer cases.
    Pakkanen S; Wahlfors T; Siltanen S; Patrikainen M; Matikainen MP; Tammela TL; Schleutker J
    J Negat Results Biomed; 2009 Dec; 8():12. PubMed ID: 20003494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.
    Chávarri-Guerra Y; Bourlon MT; Rodríguez-Olivares JL; Orozco L; Bazua D; Rodríguez-Faure A; Alcalde-Castro MJ; Castro E; Castillo D; Herzog J; Weitzel J
    Clin Genitourin Cancer; 2023 Oct; 21(5):569-573. PubMed ID: 37380563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
    Kote-Jarai Z; Leongamornlert D; Saunders E; Tymrakiewicz M; Castro E; Mahmud N; Guy M; Edwards S; O'Brien L; Sawyer E; Hall A; Wilkinson R; Dadaev T; Goh C; Easton D; ; Goldgar D; Eeles R
    Br J Cancer; 2011 Oct; 105(8):1230-4. PubMed ID: 21952622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.